​

Kyntra Bio (KYNB) Stock Forecast, Price Target & Predictions

OverviewRevenueFinancialsChartTranscripts

KYNB Stock Forecast

Kyntra Bio (KYNB) stock forecast, based on 15 Wall Street analysts, predicts a 12-month average price target of $28.00, with a high of $28.00 and a low of $28.00. This represents a 280.95% increase from the last price of $7.35.

$5 $10 $15 $20 $25 $30 High: $28 Avg: $28 Low: $28 Last Closed Price: $7.35

KYNB Stock Rating

Kyntra Bio stock's rating consensus is Hold, based on 15 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (33.33%), 8 Hold (53.33%), 2 Sell (13.33%), and 0 Strong Sell (0.00%).

Hold
Total 15 0 2 8 5 Strong Sell Sell Hold Buy Strong Buy

KYNB Price Target Upside V Benchmarks

TypeNameUpside
StockKyntra Bio280.95%
SectorHealthcare Stocks 15.45%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$7.35$7.35$7.35
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 26-11--2
Jun, 26-11--2
May, 26-11--2
Apr, 26-11--2
Mar, 26-1---1
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 02, 2023Annabel SamimyStifel Nicolaus$28.00$17.3261.66%280.95%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 06, 2026OppenheimerOutperforminitialise
Jun 09, 2026Rodman & RenshawBuyinitialise
Aug 07, 2025H.C. WainwrightBuyBuyhold
Jul 31, 2024William BlairMarket PerformMarket Performhold
Jan 30, 2023William BlairOutperformupgrade
Jan 05, 2023Bank of America SecuritiesBuyupgrade

Financial Forecast

EPS Forecast

$-25 $-10 $5 $20 $35 $50 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.48$45.37---
Avg Forecast$-20.00$-4.60$-11.95$-14.65$-8.41
High Forecast$-19.57$-4.51$-6.51$-9.16$-8.23
Low Forecast$-20.43$-4.70$-17.39$-20.14$-8.59
Surprise %-97.60%-1086.30%---

Revenue Forecast

$0 $40M $80M $120M $160M $200M Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$29.62M$6.44M---
Avg Forecast$177.85M$6.59M$6.12M$6.12M$6.20M
High Forecast$180.77M$6.83M$6.22M$6.13M$6.30M
Low Forecast$174.93M$6.34M$6.02M$6.11M$6.10M
Surprise %-83.34%-2.22%---

Net Income Forecast

$-100M $-40M $20M $80M $140M $200M Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-47.58M$183.45M---
Avg Forecast$-80.04M$-18.42M$-53.75M$-52.30M$-33.65M
High Forecast$-78.33M$-18.03M$-26.05M$-36.64M$-32.94M
Low Forecast$-81.74M$-18.82M$-69.58M$-80.60M$-34.37M
Surprise %-40.55%-1095.74%---

KYNB Forecast FAQ

Is Kyntra Bio stock a buy?

Kyntra Bio stock has a consensus rating of Hold, based on 15 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 8 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Kyntra Bio is a neutral investment for most analysts.

What is Kyntra Bio's price target?

Kyntra Bio's price target, set by 15 Wall Street analysts, averages $28 over the next 12 months. The price target range spans from $28 at the low end to $28 at the high end, suggesting a potential 280.95% change from the previous closing price of $7.35.

How does Kyntra Bio stock forecast compare to its benchmarks?

Kyntra Bio's stock forecast shows a 280.95% upside, outperforming the average forecast for the healthcare stocks sector (15.45%).

What is the breakdown of analyst ratings for Kyntra Bio over the past three months?

  • July 2026: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • June 2026: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.

What is Kyntra Bio’s EPS forecast?

Kyntra Bio's average annual EPS forecast for its fiscal year ending in December 2026 is $-11.95, marking a -126.34% decrease from the reported $45.37 in 2025. Estimates for the following years are $-14.65 in 2027, and $-8.41 in 2028.

What is Kyntra Bio’s revenue forecast?

Kyntra Bio's average annual revenue forecast for its fiscal year ending in December 2026 is $6.12M, reflecting a -5.00% decrease from the reported $6.44M in 2025. The forecast for 2027 is $6.12M, and $6.2M for 2028.

What is Kyntra Bio’s net income forecast?

Kyntra Bio's net income forecast for the fiscal year ending in December 2026 stands at $-53.75M, representing a -129.30% decrease from the reported $183.45M in 2025. Projections indicate $-52.3M in 2027, and $-33.655M in 2028.